ESPID is the world’s premier paediatric infectious diseases meeting for professionals who want to stay up to date, apply state-of-the art science to clinical care, present their research, reinforce existing and develop new collaborations.
ESPID 2023 participants will have the opportunity to attend lectures given by world-renowned researchers and scientists who are experts in infectious diseases as well as in related disciplines such as public health and epidemiology, immunology, microbiology, and more.
CCL – Centro de Congressos de Lisboa Lisboa Congress Centre
Diversity, quality, magnitude, and functionality of the humoral response to alive-attenuated tetravalent dengue vaccine in pediatric vaccinees
Efficacy and safety of Takeda’s tetravalent dengue vaccine candidate (TAK-003) after 4.5 years of follow-up: results from participants in Brazil
An open-label, Phase 2 study evaluating cell-mediated immune response and safety of a tetravalent dengue vaccine in children and adolescents aged 4-16 years
Featured Resources
View some of our features resources from congress
Video
Video
Video
PDF
PDF
VideoMedical Information
Submit a medical information request regarding our vaccine candidates through the button below.